Evidence map›Paper›PMID 33019277›Full record

ArticleAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2020

Improving wheelchair route planning through instrumentation and navigation systems.

Dzenan Dzafic, Jorge L Candiotti, Rory A Cooper

Open access · greenAbstract read
In one paragraph

Article in Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Off to the park: a geospatial investigation of adapted ride-on car usage.Disability and rehabilitation. Assistive technology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Dzenan Dzafic
Jorge L Candiotti
Rory A Cooper
VA Pittsburgh Healthcare System · USRWTH Aachen University · DE

Funding

RRD VA I50 RX002998RRD VA IK1 RX003076RRD VA IK6 RX003916
6 · The paper itself

Abstract

Route planning is an important tool to reach points of interest. The current technology offers options for public transportation and pedestrians on the road and sidewalks, respectively. However, for people who use electric powered wheelchairs (EPW) as their primary means of mobility, the level of accessibility and EPW battery consumption are important during route planning. This paper introduces the concept of an accessible route navigation application to reduce EPW battery consumption. The application, called eNav, uses five layers of information including OpenStreetMaps (OSM), airborne laser scanner (ALS), Point-of-Interests (POIs), public transportation, and crowdsourcing. eNav collects these layers of information to provide the shortest, most accessible, and most comfortable routes that consume the least amount of EPW battery. Additionally, the paper presents the Mobility Enhancement roBot (MEBot), a legged-wheeled power wheelchair, to drive over architectural barriers and less accessible environments. The paper proposes the use of MEBot as a sixth layer of information to inform eNav and road authorities about sidewalk/route conditions, to improve road accessibility, and to provide an energy efficient route planning for non-MEBot users.

Indexed as

WheelchairsArchitectural AccessibilityElectricityElectric Power SuppliesEquipment Design

Identifiers

PMID33019277
PMCPMC8883793
OpenAlexW3082457016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.